drugset / Trial / NCT06997263

Sublingual Melatonin for Anxiety and Pain in Elective Gynecologic Surgery

NCT06997263

Completed 96 enrolled Benha University
RandomizedParallel-groupSingle-blindTreatment

Summary

This prospective randomized controlled study aims to evaluate the anxiolytic effect of preoperative sublingual melatonin and its impact on postoperative pain scores when administered in two different doses to female patients undergoing elective gynecological surgeries.

Timeline

Start
2024-01-15
Primary completion
2025-01-10
Completion
2025-01-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Melatonin Small molecule 3 mg Other
Subject Melatonin Small molecule 6 mg Other

Indications